Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension

Özlem Güngör Tunçer; Mecbure Nalbantoglu; Elvan Alper Sengul; Betül Baykan

doi:10.14744/agri.2021.05025

Özlem Güngör Tunçer^¹, Mecbure Nalbantoglu^², Elvan Alper Sengul^³, Betül Baykan^⁴

¹Department of Neurology, Memorial Şişli Hospital, İstanbul, Türkiye
²Department of Neurology, Demiroğlu Bilim University, İstanbul, Türkiye
³Department of Ophtalmology, Demiroğlu Bilim University, İstanbul, Türkiye
⁴Department of Neurology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye

Keywords: Acetazolamide, intracranial hypertension; metabolic acidosis; papilledema; SARS-CoV-2 pandemic.

Abstract

We herein present a 40-year-old female physician who was diagnosed with idiopathic intracranial hypertension (IIH) 4 years ago. In the last years, the patient was in remission without any medications. Since the onset of COVID-19 pandemic, she has been stressfully working in the high-risk area, therefore using personal protective equipment (N95 mask, protective clothing, goggles, and protective cap) during the day for extended periods. Her headaches recurred and the patient was diagnosed with a relapse of IIH; acetazolamide and afterward topiramate were initiated, with diet treatment. Symptomatic metabolic acidosis, which is otherwise a rare side effect of the IIH treatment and not seen in her first attack even with higher doses, developed during the follow-up, presenting with shortness of breath and chest tightening. The emerging problems of IIH diagnosis and management during the COVID-19 pandemic will be discussed.

BibTex	`@article{ agri200, doi = {10.14744/agri.2021.05025}, author = {Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan}, title = {Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension}, journal = {Agri}, year = {2023}, volume = {35}, number = {2}, pages = {107-110}, publisher = {The Turkish Society of Algology} }`
RIS	`TY - JOUR AU - Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan PY - 2023 TI - Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension SP - 107 EP - 110 JO - The Journal of the Turkish Society of Algology J2 - Agri VL - 35 IS - 2 PB - DO - 10.14744/agri.2021.05025 ER -`
EndNote	`%0 Journal Article %A Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan %T Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension %J The Journal of the Turkish Society of Algology %D 2023 %V 35 %N 2 %P 107-110 %R 10.14744/agri.2021.05025`
APA	Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan (2023). Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension. The Journal of the Turkish Society of Algology, 35(2), 107-110. doi:10.14744/agri.2021.05025
MLA	Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan. "Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension" The Journal of the Turkish Society of Algology, vol. 35, no. 2, 2023, pp. 107-110. doi:10.14744/agri.2021.05025.
Chicago	Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan. "Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension" The Journal of the Turkish Society of Algology 35, no. 2 (2023): 107-110. https://doi.org/10.14744/agri.2021.05025.
AMA	Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan. Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension. Agri. 2023; 35(2): 107-110. doi:10.14744/agri.2021.05025.
Vancouver	Özlem Güngör Tunçer, Mecbure Nalbantoglu, Elvan Alper Sengul, Betül Baykan. Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension. Agri. 2023; 35(2): 107-110. doi:10.14744/agri.2021.05025

Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension

Abstract

Cite As